Valorising magnetometry in cells
This project aims to commercialize diamond magnetometry for measuring free radical generation in living cells, potentially leading to a startup focused on innovative diagnostic solutions.
Projectdetails
Introduction
Magnetic resonance spectroscopy (NMR or ESR) and magnetic resonance imaging (MRI) are widely used. However, magnetic resonance signals are low in energy and thus difficult to detect. These techniques are expensive and typically only offer millimeter down to micrometer resolution. Diamond magnetometry potentially offers a solution. The technique is based on a quantum effect and allows even the detection of single electron spins. While the technique has been used for a few years in physics, during my ERC project, this powerful tool was utilized for the first time to measure metabolic activity in living cells.
Project Aim
The aim of this project is to explore the commercial potential of these results and, if deemed feasible, found a start-up company for exploitation.
Application Focus
As a first application, we will investigate free radical generation. These molecules play a key role in many biological processes, including:
- Cell communication
- Immune responses
- Ageing
Additionally, they are an indicator of stress and thus play a role in many diseases, including:
- Cancer
- Cardiovascular diseases
- Viral and bacterial infections
Despite their relevance and the fact that free radical generation is often an early sign of disease, they are rarely used as biomarkers since they are notoriously difficult to measure.
Prototype Development
In this project, we will build a prototype (to be patented) that can be used for demonstrations to customers. This will be done in close collaboration with a user committee in order to meet customer expectations.
Demonstration and Business Model
To demonstrate the usefulness to customers for diagnosis, we will conduct test measurements. Further, we will assess whether a business model based on a product, based on services, or a hybrid business model containing both is most promising.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 150.000 |
Totale projectbegroting | € 150.000 |
Tijdlijn
Startdatum | 1-10-2022 |
Einddatum | 31-3-2024 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- ACADEMISCH ZIEKENHUIS GRONINGENpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Signal-enhanced MRI contrast agents for neurodegenerationThis project aims to develop and validate new magnetic resonance technologies for early, non-invasive diagnosis of neurodegenerative diseases using metabolic contrast agents. | ERC Proof of... | € 150.000 | 2022 | Details |
Radiation-detected NMR: new dimension for Magnetic Resonance spectroscopy and imagingThis project aims to develop a modular insert for conventional NMR and MRI spectrometers to enhance sensitivity through in-situ polarisation of longer-lived nuclei using radiation-detected NMR. | ERC Proof of... | € 150.000 | 2023 | Details |
Hyperpolarized Magnetic Resonance at the point-of-careHYPMET aims to revolutionize personalized cancer treatment by developing a compact NMR technology for real-time monitoring of metabolic pathways and body fluid analyses using enhanced hyperpolarization methods. | ERC Starting... | € 1.499.968 | 2024 | Details |
A companion magnetic sensor for in operando detection of magnetic biosynthesis in cancer and neurodegenerative modelsThe BioMag PoC project aims to develop a sensitive magnetic sensor for real-time monitoring of intracellular magnetic iron biosynthesis, potentially leading to novel therapies for cancer and Alzheimer's. | ERC Proof of... | € 150.000 | 2022 | Details |
Nanoscale Integrated Magnetic Field SensorDevelop a low-cost, nano-sized magnetoresistive sensor with an extended sensing range and reduced power consumption for applications in IoT, wearables, and automotive technologies. | ERC Proof of... | € 150.000 | 2023 | Details |
Signal-enhanced MRI contrast agents for neurodegeneration
This project aims to develop and validate new magnetic resonance technologies for early, non-invasive diagnosis of neurodegenerative diseases using metabolic contrast agents.
Radiation-detected NMR: new dimension for Magnetic Resonance spectroscopy and imaging
This project aims to develop a modular insert for conventional NMR and MRI spectrometers to enhance sensitivity through in-situ polarisation of longer-lived nuclei using radiation-detected NMR.
Hyperpolarized Magnetic Resonance at the point-of-care
HYPMET aims to revolutionize personalized cancer treatment by developing a compact NMR technology for real-time monitoring of metabolic pathways and body fluid analyses using enhanced hyperpolarization methods.
A companion magnetic sensor for in operando detection of magnetic biosynthesis in cancer and neurodegenerative models
The BioMag PoC project aims to develop a sensitive magnetic sensor for real-time monitoring of intracellular magnetic iron biosynthesis, potentially leading to novel therapies for cancer and Alzheimer's.
Nanoscale Integrated Magnetic Field Sensor
Develop a low-cost, nano-sized magnetoresistive sensor with an extended sensing range and reduced power consumption for applications in IoT, wearables, and automotive technologies.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Magnetic Resonance at the Scale of a CellThe HyperCell project aims to revolutionize cell research by developing a non-invasive benchtop tool for single-cell metabolic analysis, enhancing understanding of diseases and treatment responses. | EIC Transition | € 1.998.750 | 2024 | Details |
Single Molecule Nuclear Magnetic Resonance Microscopy for Complex Spin SystemsThis project aims to enhance NMR sensitivity to single molecules using scanning probe microscopy, enabling groundbreaking insights in nanotechnology and impacting NMR and SPM markets. | EIC Pathfinder | € 2.994.409 | 2023 | Details |
MIRACLE the platform for virtual biopsies; introducing Metabolic MRI-as-a-Service for oncologic careMIRACLE aims to develop a non-invasive MRI add-on for virtual biopsies, enabling personalized cancer treatment decisions by providing structural and metabolic tumor information globally. | EIC Transition | € 2.495.127 | 2022 | Details |
Early detection of treatment response in breast cancerThe project aims to enhance breast cancer treatment through Hyperpolarized Magnetic Resonance imaging for early detection of non-responders, improving outcomes and reducing side effects. | EIC Transition | € 2.499.229 | 2024 | Details |
Mid-infrared Wearable for Non-invasive biomarker monitoringThe project aims to develop a wearable device using a miniature Mid-Infrared spectrometer for non-invasive biomarker detection in metabolic syndrome, enhancing early diagnosis and management. | EIC Pathfinder | € 3.991.297 | 2024 | Details |
Magnetic Resonance at the Scale of a Cell
The HyperCell project aims to revolutionize cell research by developing a non-invasive benchtop tool for single-cell metabolic analysis, enhancing understanding of diseases and treatment responses.
Single Molecule Nuclear Magnetic Resonance Microscopy for Complex Spin Systems
This project aims to enhance NMR sensitivity to single molecules using scanning probe microscopy, enabling groundbreaking insights in nanotechnology and impacting NMR and SPM markets.
MIRACLE the platform for virtual biopsies; introducing Metabolic MRI-as-a-Service for oncologic care
MIRACLE aims to develop a non-invasive MRI add-on for virtual biopsies, enabling personalized cancer treatment decisions by providing structural and metabolic tumor information globally.
Early detection of treatment response in breast cancer
The project aims to enhance breast cancer treatment through Hyperpolarized Magnetic Resonance imaging for early detection of non-responders, improving outcomes and reducing side effects.
Mid-infrared Wearable for Non-invasive biomarker monitoring
The project aims to develop a wearable device using a miniature Mid-Infrared spectrometer for non-invasive biomarker detection in metabolic syndrome, enhancing early diagnosis and management.